Amgen Receives Positive CHMP Opinion For ABP 501 (Biosimilar Adalimumab) For The Treatment Of Certain Inflammatory Diseases
First Adalimumab Biosimilar Candidate Recommended for EMA Approval
THOUSAND OAKS, Calif., Jan. 27, 2017 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion for the Marketing Authorization of ABP 501 (biosimilar adalimumab), recommending approval for all available indications. ABP 501 has been recommended for approval for the treatment of certain inflammatory diseases in adults, including moderate-to-severe rheumatoid arthritis, psoriatic arthritis, severe ankylosing spondylitis (AS), se...
Source: Amgen News Release - January 27, 2017 Category: Pharmaceuticals Tags: Uncategorized Source Type: news
Indonesian woman's rigid spine from Ankylosing Spondylitis
Pictures show 35-year-old Sulami a woman from the Sragen area of Central Java, in the grip of a disease that has turned her completely rigid. (Source: the Mail online | Health)
Source: the Mail online | Health - January 19, 2017 Category: Consumer Health News Source Type: news
Benefits of Secukinumab in Ankylosing Spondylitis May Persist at Two Years Benefits of Secukinumab in Ankylosing Spondylitis May Persist at Two Years
Secukinumab appears to improve clinical and radiographic outcomes of ankylosing spondylitis (AS) through two years of therapy, according to new results from the MEASURE 1 study.Reuters Health Information (Source: Medscape Orthopaedics Headlines)
Source: Medscape Orthopaedics Headlines - January 17, 2017 Category: Orthopaedics Tags: Rheumatology News Source Type: news
Janssen Submits Two Applications To FDA Seeking Approval Of Simponi Aria ® (Golimumab) For The Treatment Of Active Psoriatic Arthritis And Active Ankylosing Spondylitis
(Source: Johnson and Johnson)
Source: Johnson and Johnson - December 21, 2016 Category: Pharmaceuticals Source Type: news
Combination Therapy May Slow Progression of Ankylosing Spondylitis
No abstract available (Source: Lippincott's Bone and Joint Newsletter)
Source: Lippincott's Bone and Joint Newsletter - December 16, 2016 Category: Orthopaedics Tags: Trends and Innovations Source Type: news
Statins Cut Mortality in Seronegative Spondyloarthropathies Statins Cut Mortality in Seronegative Spondyloarthropathies
Patients with ankylosing spondylitis or psoriatic arthritis might benefit from statin treatment, a new study shows.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 14, 2016 Category: Consumer Health News Tags: Rheumatology News Source Type: news
New Phase 3 Data Show Simponi Aria ® (Golimumab) Significantly Improved Signs And Symptoms In Patients With Active Ankylosing Spondylitis
Patients with Painful Inflammatory Spinal Arthritis Showed Marked Improvements in Multiple Study Endpoints Following Treatment with SIMPONI ARIA ® (Source: Johnson and Johnson)
Source: Johnson and Johnson - November 14, 2016 Category: Pharmaceuticals Source Type: news
Combination of NSAIDs and TNF-inhibitors shows benefit for ankylosing spondylitis
A combination of nonsteroidal anti-inflammatory drugs and TNF-inhibitors may help slow down spine damage in ankylosing spondylitis, according to new research findings. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - November 13, 2016 Category: Science Source Type: news
Fine-Tuning Treatment for Ankylosing Spondylitis (CME/CE)
(MedPage Today) -- Focus is on specific clinical situations, and hope now is for guideline update in light of new options (Source: MedPage Today Pain Management)
Source: MedPage Today Pain Management - November 13, 2016 Category: Anesthesiology Source Type: news
AS: Is Tofacitinib the Next Big Thing? (CME/CE)
(MedPage Today) -- ' Field of ankylosing spondylitis management has suddenly come alive ' (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - November 13, 2016 Category: Rheumatology Source Type: news
AS: Is Xeljanz the Next Big Thing? (CME/CE)
(MedPage Today) -- ' Field of ankylosing spondylitis management has suddenly come alive ' (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - November 13, 2016 Category: Primary Care Source Type: news
Medical News Today: Statins could cut death risk by a third for some arthritis patients
Researchers find statins could lower the risk of death for patients with psoriatic arthritis and ankylosing spondylitis by reducing inflammation. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - November 13, 2016 Category: Consumer Health News Tags: Arthritis / Rheumatology Source Type: news
Ankylosing Spondylitis and fibromyalgia: Woman describes treatment 'life-changing'
A WOMAN who suffers from debilitating illnesses Ankylosing Spondylitis and Fibromyalgia has found a way of easing her pain which she has described as 'life-changing'. (Source: Daily Express - Health)
Source: Daily Express - Health - November 7, 2016 Category: Consumer Health News Source Type: news
RheumNow: POSTURE Study
(MedPage Today) -- Apremilast fails in ankylosing spondylitis (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - November 1, 2016 Category: Primary Care Source Type: news
FDA Approves Amgen's AMJEVITA ™ (Adalimumab-Atto) For Treatment Of Seven Inflammatory Diseases
First Regulatory Approval for Company's Biosimilar Portfolio
First Biosimilar Adalimumab Approved by FDA
THOUSAND OAKS, Calif., Sept. 23, 2016 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved AMJEVITA™ (adalimumab-atto) across all eligible indications of the reference product, Humira® (adalimumab). AMJEVITA is the first adalimumab biosimilar approved by the FDA and has been approved for the treatment of seven inflammatory diseases, including moderate-to-severe rheumatoid arthritis, moderate-to-severe polyarticular juvenile idiopathic arthritis, pso...
Source: Amgen News Release - September 23, 2016 Category: Pharmaceuticals Tags: Uncategorized Source Type: news
